CCR6 and hepatocellular carcinoma: Furthermore, in the co‐culture of IR‐LX2 CM‐stimulated THP‐1 CM and IR‐HCC cells, CCL20 neutralising antibody, CCR6 inhibitor or JSH‐23 treatment increased cell apoptosis and inhibited ALKBH5/TIRAP axis (Figure 5G,H).